A drug discovery and advancement company.

We have become excited about 2011, as we expect Stage II results for both the hepatocellular cancer SHELTER study and the Hodgkin’s lymphoma SAPHIRE study.’.. 4SC initiates dosing in resminostat Phase I/II SHORE research for KRAS-mutant colorectal cancer 4SC AG , a drug discovery and advancement company, today declared that the first patient has been dosed in the Phase I/II SHORE research with the oral pan-histone deacetylase inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant tumor.Shah, and Harlan M. Krumholz, M.D. The scholarly study was funded in part by the Pew Charitable Trusts. JAMA doi: 10.1001/jama.2013.282034.

Alcoholism – one of the top healthcare crises in the world Alcoholism is a chronic disease that often requires intensive continuing treatment for long term recovery, according to ‘Alcoholism: Treatment and Recovery,’ a written report by the Caron Base. Alcohol abuse is the third highest cause of preventable death in the United States and the most common drug of misuse among people who receive addiction treatment.